Successful treatment of aggressive AA amyloidosis with tocilizumab in a patient with polymyalgia rheumatica

Nuh Atas1, Ali Rıza Çalışkan2, Ayşenur Akatlı3

  • 1Division of Rheumatology, Department of Internal Medicine, Adıyaman Education and Research Hospital, Adıyaman, Turkey.

PubMed

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K